Works matching DE "CERTOLIZUMAB pegol"

Results: 115

Pharmacogenomics of TNF inhibitors.

Published in:

Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1521794

By:

Jan, Zainab;
El Assadi, Farah;
Velayutham, Dinesh;
Mifsud, Borbala;
Jithesh, Puthen Veettil

Publication type:

Article

Drug Adherence and Persistence of Patients with Moderate to Severe Psoriasis Treated with Biologic Medications in a US Commercially Insured Population.

Published in:

Dermatology (10188665), 2022, v. 238, n. 3, p. 438, doi. 10.1159/000519176

By:

Xu, Chang;
Teeple, Amanda;
Wu, Bingcao;
Fitzgerald, Timothy;
Feldman, Steven R.

Publication type:

Article

Psoriasis: Sind Geschlechtsunterschiede bedeutsam?

Published in:

Kompass Dermatologie, 2024, v. 12, n. 4, p. 222, doi. 10.1159/000542073

By:

Sticherling, Michael

Publication type:

Article

Minimal change nephrotic syndrome due to certolizumab pegol, an anti-tumor necrosis factor-alpha monoclonal antibody for treatment of rheumatoid arthritis.

Published in:

Rheumatology Advances in Practice, 2022, v. 6, n. 1, p. 1, doi. 10.1093/rap/rkac012

By:

Sugiyama, Masafumi;
Okuda, Saki;
Hirooka, Yasuaki

Publication type:

Article

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 3, p. 693, doi. 10.1007/s40744-023-00541-5

By:

Bykerk, Vivian P.;
Nash, Peter;
Nicholls, David;
Tanaka, Yoshiya;
Winthrop, Kevin;
Popova, Christina;
Tilt, Nicola;
Haaland, Derek

Publication type:

Article

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons.

Published in:

Rheumatology & Therapy, 2023, v. 10, n. 2, p. 307, doi. 10.1007/s40744-022-00522-0

By:

Akkoç, Nurullah;
Arteaga, Carlos H.;
Auteri, Simone E.;
Betts, Marissa;
Fahrbach, Kyle;
Kim, Mindy;
Kiri, Sandeep;
Neupane, Binod;
Gaffney, Karl;
Mease, Philip J.

Publication type:

Article

Certolizumab Pegol Treatment in Patients with Axial-Spondyloarthritis-Associated Acute Anterior Uveitis: a Narrative Review.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 6, p. 1481, doi. 10.1007/s40744-022-00486-1

By:

van der Horst-Bruinsma, Irene E.;
Robinson, Philip C.;
Favalli, Ennio G.;
Verbraak, Frank D.;
Kim, Mindy;
Kumke, Thomas;
Bauer, Lars;
Hoepken, Bengt;
Deodhar, Atul

Publication type:

Article

Association between TNFi anti-drug antibodies, smoking, and disease activity in patients with inflammatory arthritis: Results from a Norwegian cross-sectional observational study.

Published in:

Rheumatology & Therapy, 2022, v. 9, n. 4, p. 1171, doi. 10.1007/s40744-022-00464-7

By:

Michelsen, Brigitte;
Berget, Kristine Thomassen;
Kavanaugh, Arthur;
Haugeberg, Glenn

Publication type:

Article

Non-Infectious Uveitis and Pregnancy, is There an Optimal Treatment? Uveitis Course and Safety of Uveitis Treatment in Pregnancy.

Published in:

Ocular Immunology & Inflammation, 2024, v. 32, n. 8, p. 1819, doi. 10.1080/09273948.2023.2296030

By:

Ting, Magdalene Yin Lin;
Vega-Tapia, Fabian;
Anguita, Rodrigo;
Cuitino, Loreto;
Valenzuela, Rodrigo A.;
Salgado, Felipe;
Valenzuela, Omar;
Ibañez, Sebastian;
Marchant, Ruben;
Urzua, Cristhian A.

Publication type:

Article

Paradoxical eruption exclusively located on the ear in patients with psoriasis treated with biologics: a case series.

Published in:

Clinical & Experimental Dermatology, 2024, v. 49, n. 8, p. 899, doi. 10.1093/ced/llae054

By:

Burlando, Martina;
Salvi, Ilaria;
Parodi, Aurora;
Cozzani, Emanuele C

Publication type:

Article

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post‐hoc analysis of clinical trials.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 7, p. 1248, doi. 10.1111/1756-185X.14699

By:

Tanaka, Yoshiya;
Takeuchi, Tsutomu;
Haaland, Derek;
Hall, Stephen;
Inanc, Nevsun;
Li, Zhanguo;
Xavier, Ricardo M.;
Cara, Carlos;
Tilt, Nicola;
Taylor, Peter C.

Publication type:

Article

Current aspects for the treatment of axial spondyloarthritis.

Published in:

International Journal of Rheumatic Diseases, 2023, v. 26, n. 1, p. 5, doi. 10.1111/1756-185X.14473

By:

Ku, Chiao‐Hsin;
Lee, Yung‐Heng;
Wei, James Cheng‐Chung;
Braun, Jürgen

Publication type:

Article

Tumor Necrosis Factor a Inhibitor-Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol.

Published in:

Cutis, 2022, v. 109, n. 6, p. E18, doi. 10.12788/cutis.0554

By:

Crasto Jr, David Walton;
Touma, Loren;
Roy, David

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study.

Published in:

Modern Rheumatology, 2024, v. 34, n. 6, p. 1103, doi. 10.1093/mr/roae019

By:

Kameda, Hideto;
Nishida, Keiichiro;
Nanki, Toshihiro;
Watanabe, Akira;
Oshima, Yukiya;
Momohara, Shigeki

Publication type:

Article

Long-term retention rates of anti-tumour necrosis factor and anti-interleukin-17 antibodies for patients with psoriatic arthritis.

Published in:

Modern Rheumatology, 2024, v. 34, n. 5, p. 1013, doi. 10.1093/mr/road111

By:

Takami, Kenji;
Tsuji, Shigeyoshi;
Sato, Sachina;
Akaji, Kazuya;
Yamashita, Chigusa;
Hiroumi, Shiori;
Konaka, Hachiro;
Hayashi, Misa;
Higashiyama, Mari

Publication type:

Article

Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab.

Published in:

Modern Rheumatology, 2023, v. 33, n. 6, p. 1097, doi. 10.1093/mr/roac138

By:

Shinya Hagiwara;
Hiroto Tsuboi;
Yuki Kuroda;
Tomonori Sawabe;
Nana Uematsu;
Fumina Kawashima;
Toshiki Sugita;
Mayu Terasaki;
Fumika Honda;
Mizuki Yagishita;
Yuya Kondo;
Takayuki Sumida;
Isao Matsumoto

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study.

Published in:

Modern Rheumatology, 2023, v. 33, n. 3, p. 460, doi. 10.1093/mr/roac073

By:

Hideto Kameda;
Keiichiro Nishida;
Toshihiro Nanki;
Akira Watanabe;
Yukiya Oshima;
Shigeki Momohara

Publication type:

Article

Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study.

Published in:

Modern Rheumatology, 2023, v. 33, n. 3, p. 460, doi. 10.1093/mr/roac073

By:

Hideto Kameda;
Keiichiro Nishida;
Toshihiro Nanki;
AkiraWatanabe;
Yukiya Oshima;
Shigeki Momohara

Publication type:

Article

Comparison of Real-World On-Label Treatment Persistence in Patients with Psoriatic Arthritis Receiving Guselkumab Versus Subcutaneous Tumor Necrosis Factor Inhibitors.

Published in:

Drugs - Real World Outcomes, 2024, v. 11, n. 3, p. 487, doi. 10.1007/s40801-024-00428-z

By:

Walsh, Jessica A.;
Lin, Iris;
Zhao, Ruizhi;
Shiff, Natalie J.;
Morrison, Laura;
Emond, Bruno;
Yu, Louise H.;
Schwartzbein, Samuel;
Lefebvre, Patrick;
Pilon, Dominic;
Chakravarty, Soumya D.;
Mease, Philip

Publication type:

Article

Renal sarcoidosis associated with certolizumab pegol treatment for psoriatic arthritis.

Published in:

Oxford Medical Case Reports, 2022, v. 2022, n. 12, p. 1, doi. 10.1093/omcr/omac133

By:

Hum, Ryan M;
Kanigicherla, Durga A;
Ho, Pauline

Publication type:

Article

Population PK modeling of certolizumab pegol in pregnant women with chronic inflammatory diseases.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 11, p. 1904, doi. 10.1002/psp4.13220

By:

Menshykau, Denis;
Sidhu, Jagdev;
Shaughnessy, Laura;
Lledo‐Garcia, Rocio;
Dua, Pinky;
Teil, Marie;
Khandelwal, Akash

Publication type:

Article

Comparisons of infection events associated with tumor necrosis factor inhibitors in patients with inflammatory arthritis: A systematic review and network meta-analysis.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1376262

By:

Ziwei Jiang;
Yue Zou;
Guangyao Li;
Sixuan Zhao;
Wei Zhang

Publication type:

Article

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1169327

By:

Mingming Li;
Ruxu You;
Yuyong Su;
Hongbo Zhou;
Shiwei Gong

Publication type:

Article

Considerations for the Use of Biologics in Pregnancy.

Published in:

Cutis, 2024, v. 114, n. 4, p. 101, doi. 10.12788/cutis.1099

By:

Yaghi, Marita;
Murase, Emi M.;
Murase, Jenny E.

Publication type:

Article

Granulomatous Hepatitis Treated With Certolizumab Pegol.

Published in:

ACG Case Reports Journal, 2024, v. 11, n. 4, p. 1, doi. 10.14309/crj.0000000000001310

By:

Brittan, Kevin;
Fiedler, Alexandra;
Scholten, Kyle;
Songtanin, Busara;
Manatsathit, Shane

Publication type:

Article

Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.

Published in:

Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-52016-4

By:

Larid, Guillaume;
Baudens, Guy;
Tiemdjo-Djimaffo, Georges;
Coquerelle, Pascal;
Goeb, Vincent;
Guyot, Marie Hélène;
Marguerie, Laurent;
Maury, Frédéric;
Veillard, Eric;
Houvenagel, Eric;
Salmon, Jean-Hugues;
Flipo, René-Marc;
Gervais, Elisabeth

Publication type:

Article

Real-world retention rates of biologics in patients with rheumatoid arthritis.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-48537-z

By:

Takami, Kenji;
Tsuji, Shigeyoshi

Publication type:

Article

Anti-TNF-α therapy induced psoriasis in rheumatoid arthritis patients according to FDA postmarketing surveillance data.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37010-6

By:

Joulfayan, Haroutyun;
Makunts, Tigran;
Abagyan, Ruben

Publication type:

Article

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas.

Published in:

Nature Communications, 2022, v. 13, p. 1, doi. 10.1038/s41467-022-33719-6

By:

Paik, Paul K.;
Luo, Jia;
Ai, Ni;
Kim, Rachel;
Ahn, Linda;
Biswas, Anup;
Coker, Courtney;
Ma, Wanchao;
Wong, Phillip;
Buonocore, Darren J.;
Lai, W. Victoria;
Chaft, Jamie E.;
Acharyya, Swarnali;
Massagué, Joan;
Kris, Mark G.

Publication type:

Article

Growth in the Cost of Biologics in Medicare Beneficiaries, 2017 to 2019.

Published in:

Journal of Clinical & Aesthetic Dermatology, 2024, v. 17, n. 7, p. 17

By:

LABORADA, JENNIFER;
SHIN, LEAH;
LEE, CLAUDIA;
SHAHSAVARI, SHAHIN;
EGEBERG, ALEXANDER;
WU, JASHIN J.

Publication type:

Article

MRI in axial spondyloarthritis: redefining diagnostic and assessment paradigms.

Published in:

ARP Rheumatology, 2024, v. 3, n. 4, p. 254, doi. 10.63032/SKWB5258

By:

Weddell, J.;
Marzo-Ortega, H.;
Machado, P. M.

Publication type:

Article

Preconception counseling impact in pregnancy outcomes in patients with spondyloarthritis.

Published in:

ARP Rheumatology, 2024, v. 3, n. 2, p. 106, doi. 10.63032/PZAR1946

By:

Beirão, T.;
Nicolau, R.;
Santos, I.;
Guimarães, F.;
Aguiar, F.;
Ganhão, S.;
Rodrigues, M.;
Filipa, N.;
Rocha, A.;
Monteiro, S.;
Videira, T.;
Brito, I.

Publication type:

Article

Biologics Imperative: Drug Positioning After First-Line Treatment with Anti-TNFs.

Published in:

Digestive Diseases & Sciences, 2023, v. 68, n. 7, p. 2785, doi. 10.1007/s10620-023-07898-1

By:

Innocenti, Tommaso

Publication type:

Article

Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery.

Published in:

2022

By:

Dai, Cong;
Huang, Yu-hong

Publication type:

Letter

A real-world retrospective study on biologics utilization in patients with psoriasis in Greece during the period 2015–2020.

Published in:

Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03147-1

By:

Lazaridou, E.;
Kourlaba, G.;
Lampropoulou, D. I.;
Gounelas, G.;
Tsolakidis, A.;
Mathioudakis, K.;
Apalla, Z.

Publication type:

Article

Adoption of newly FDA-approved targeted immunomodulatory therapies by dermatologists: a cross-sectional analysis of Medicare Part D claims from 2013 to 2018.

Published in:

Archives of Dermatological Research, 2023, v. 315, n. 3, p. 673, doi. 10.1007/s00403-022-02422-3

By:

Dean, Owen;
Tausk, Francisco;
Singh, Partik

Publication type:

Article

Estimating Patient-Specific Relative Benefit of Adding Biologics to Conventional Rheumatoid Arthritis Treatment: An Individual Participant Data Meta-Analysis.

Published in:

JAMA Network Open, 2023, v. 6, n. 6, p. e2321398, doi. 10.1001/jamanetworkopen.2023.21398

By:

Luo, Yan;
Chalkou, Konstantina;
Funada, Satoshi;
Salanti, Georgia;
Furukawa, Toshi A.

Publication type:

Article

Current usage of and perspectives on the use of MRI to assess treatment non-response in axial spondyloarthritis: a UK-based survey.

Published in:

Rheumatology Advances in Practice, 2024, v. 8, n. 4, p. 1, doi. 10.1093/rap/rkae139

By:

Weddell, Jake;
Bray, Timothy J P;
Sengupta, Raj;
McGonagle, Dennis;
Machado, Pedro M;
Marzo-Ortega, Helena

Publication type:

Article

Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial.

Published in:

Arthritis & Rheumatology, 2024, v. 76, n. 3, p. 363, doi. 10.1002/art.42730

By:

Lend, Kristina;
Koopman, Frieda A.;
Lampa, Jon;
Jansen, Gerrit;
Hetland, Merete L.;
Uhlig, Till;
Nordström, Dan;
Nurmohamed, Michael;
Gudbjornsson, Bjorn;
Rudin, Anna;
Østergaard, Mikkel;
Heiberg, Marte S.;
Sokka‐Isler, Tuulikki;
Hørslev‐Petersen, Kim;
Haavardsholm, Espen A.;
Grondal, Gerdur;
Twisk, Jos W. R.;
van Vollenhoven, Ronald

Publication type:

Article

Biologic treatment outcomes in generalized pustular psoriasis of pregnancy: A systematic review.

Published in:

Australasian Journal of Dermatology, 2024, v. 65, n. 8, p. 650, doi. 10.1111/ajd.14357

By:

Wang, YuFei;
Zhou, ChaoJing;
Hou, YiYun;
Gao, YaMei;
Lu, JiLiang;
Yin, ZhiQiang

Publication type:

Article

Impact of Non-Persistence on Healthcare Resource Utilization and Costs in Patients With Immune-Mediated Rheumatic Diseases Initiating Subcutaneous TNF-Alpha Inhibitors: A Before-and-After Study.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.752879

By:

Carballo, Nuria;
Garcia-Alzórriz, Enric;
Ferrández, Olivia;
Navarrete-Rouco, María Eugenia;
Durán-Jordà, Xavier;
Pérez-García, Carolina;
Monfort, Jordi;
Cots, Francesc;
Grau, Santiago

Publication type:

Article

Corrigendum: TNF-α in Uveitis: From Bench to Clinic.

Published in:

2022

By:

Jiang, Qi;
Li, Zhaohuai;
Tao, Tianyu;
Duan, Runping;
Wang, Xianggui;
Su, Wenru

Publication type:

Correction Notice

TNF-α in Uveitis: From Bench to Clinic.

Published in:

Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2021.740057

By:

Jiang, Qi;
Li, Zhaohuai;
Tao, Tianyu;
Duan, Runping;
Wang, Xianggui;
Su, Wenru

Publication type:

Article

Certolizumab pegol in the treatment of severe hidradenitis suppurativa after adalimumab failure: A real‐life experience.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 11, p. 1, doi. 10.1111/dth.15782

By:

Esme, Pelin;
Akoglu, Gulsen;
Dalkıran, Cansu Dogan;
Caliskan, Ercan

Publication type:

Article

Refractory folliculitis decalvans treated with biologics: Case series in 4 situations.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 10, p. 1, doi. 10.1111/dth.15778

By:

Lobato‐Berezo, Alejandro;
Pujol, Ramon M.

Publication type:

Article

Certolizumab pegol as an alternative treatment in patients with coexisting hidradenitis suppurativa and other inflammatory immune‐mediated diseases: Report of two cases.

Published in:

Dermatologic Therapy, 2022, v. 35, n. 5, p. 1, doi. 10.1111/dth.15401

By:

Melgosa Ramos, Francisco Javier;
García Ruiz, Ramón;
Mateu Puchades, Almudena

Publication type:

Article

Association Between Biologic Exposure and the Risk of Depression in Patients with Psoriasis: A Retrospective Analysis of Large US Administrative Claims Data.

Published in:

2024

By:

Strober, Bruce;
Soliman, Ahmed M.;
Truong, Bang;
Patel, Manish B.;
Barqawi, Yazan K.;
Gisondi, Paolo

Publication type:

Letter

Treatment adherence and persistence of seven commonly prescribed biologics for moderate to severe psoriasis and psoriatic arthritis in a U.S. commercially insured population.

Published in:

Journal of Dermatological Treatment, 2022, v. 33, n. 4, p. 2270, doi. 10.1080/09546634.2021.1950600

By:

Xu, Chang;
Teeple, Amanda;
Wu, Bingcao;
Fitzgerald, Timothy;
Feldman, Steven R.

Publication type:

Article

Drug survival of secukinumab, ustekinumab, and certolizumab pegol in psoriasis: a 2-year, monocentric, retrospective study.

Published in:

Journal of Dermatological Treatment, 2022, v. 33, n. 3, p. 1749, doi. 10.1080/09546634.2020.1854428

By:

Chatzimichail, Giannis;
Günther, Julia;
Ständer, Sascha;
Thaçi, Diamant

Publication type:

Article

Secukinumab during pregnancy: a case report and review of literature.

Published in:

Journal of Dermatological Treatment, 2022, v. 33, n. 1, p. 585, doi. 10.1080/09546634.2020.1750551

By:

Gallo, L.;
Ruggiero, A.;
Balato, A.;
Megna, M.;
Fabbrocini, G.

Publication type:

Article